Protagenic Therapeutics resolves Nasdaq delisting notice, regains compliance with bid price rule

Protagenic Therapeutics, Inc.new

Regained compliance with Nasdaq Listing Rule 5550(a)(2) on March 19, 2024.
Closing bid price stayed above $1.00 for ten consecutive trading days (Mar 5-18, 2024).
Previously faced potential delisting by May 19, 2024; notice now closed.
Original deficiency notice received Nov 21, 2023 for bid price below $1.00 for 30 days.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.